ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences - Feb. 6, 2020

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

• Guggenheim Healthcare Talks Oncology Day
  February 13^th at 3:00 pm Eastern
• SVB Leerink 9^th Annual Global Healthcare Conference
  February 26^th at 10:30 am Eastern
• Cowen 40^th Annual Healthcare Conference
  March 2^nd at 11:20 am Eastern

A webcast of each presentation will be accessible through the Investors and Media section of the Company's website on www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200206005013/en/